Bertil Lindmark - 04 Jan 2022 Form 4 Insider Report for Galecto, Inc. (GLTO)

Role
Chief Medical Officer
Signature
/s/ Lori Firmani, attorney-in-fact
Issuer symbol
GLTO
Transactions as of
04 Jan 2022
Net transactions value
$0
Form type
4
Filing time
06 Jan 2022, 16:00:36 UTC
Previous filing
28 Jun 2021
Next filing
23 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GLTO Stock Option (right to buy) Award $0 +118,750 $0.000000 118,750 04 Jan 2022 Common Stock 118,750 $3.24 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to such option vested and became exercisable on January 4, 2023 and the remainder of the shares vest in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.